Home » Topics » BioWorld Science

BioWorld Science
RSS

SHP-1 abundance determines the responsiveness of an individual NK cell

Nov. 26, 2021

Attenuated measles vaccine expressing the S antigen protects mice and hamsters from SARS-CoV-2

Nov. 26, 2021

Repurposing of riluzole for the treatment of Niemann-Pick disease, type C1

Nov. 26, 2021

Glycotope's tumor-targeting IL-15-based immunocytokine shows efficacy in preclinical models

Nov. 26, 2021

Study reports tumors change as patients age

Nov. 26, 2021

Sinocelltech patents Fc fragment fusion protein glycoconjugates

Nov. 26, 2021

Merck, Cancer Research Technology divulge YAP1/TEAD interaction inhibitors

Nov. 26, 2021

Takeda Pharmaceutical presents new ABCC2 inhibitors

Nov. 26, 2021

New MAP4K1 inhibitors synthesized at Pfizer

Nov. 26, 2021

Adenosine A2A receptor antagonists identified at Adorx Therapeutics

Nov. 26, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 29, 2026.
TROP2 ADCs progress into first-line for lung, breast cancers
BioWorld
Multiple updates on TROP2-directed antibody-drug conjugates (ADCs) for lung and breast cancers highlight both progress made and opportunities for improvement for...
New evidence links autoimmunity to long COVID symptoms
BioWorld
Recent findings are reshaping current understanding of the post-infection landscape of SARS-CoV-2. Although previous studies had already suggested that...
Will Ovid’s golden age of KCC2 metamorph CNS?
BioWorld
The “deep dive” April 8 by Ovid Therapeutics Inc. into potassium-chloride co-transporter 2 (KCC2) research included company officials and independent experts in...
Breakthrough as GSK’s bepirovirsen clears 19% of chronic hep B infections
BioWorld
GSK plc has announced a breakthrough in the treatment of chronic hepatitis B, reporting a functional cure rate of 19% across two phase III trials of its antisense...